Replimune Group Files 8-K on Financials
Ticker: REPL · Form: 8-K · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: financial-condition, operations, filing
TL;DR
Replimune Group dropped an 8-K on Nov 12th detailing their financials. Check the exhibits for the deets.
AI Summary
Replimune Group, Inc. filed an 8-K on November 12, 2024, reporting on its results of operations and financial condition. The filing details financial statements and exhibits related to the company's business operations. Specific financial figures and operational outcomes are expected to be detailed within the accompanying exhibits.
Why It Matters
This filing provides crucial updates on Replimune Group's financial health and operational performance, which are key indicators for investors and stakeholders.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant financial and operational updates that may impact a company's stock price, requiring careful review.
Key Players & Entities
- Replimune Group, Inc. (company) — Registrant
- November 12, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38596 (company_id) — Commission File Number
- 82-2082553 (company_id) — IRS Employer Identification Number
- 500 Unicorn Park Drive Suite 303 Woburn, MA 01801 (address) — Address of principal executive offices
- ( 781 ) 222-9600 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits,' but the specific details are within the attached documents.
When was the earliest event reported in this filing?
The earliest event reported was on November 12, 2024.
What is Replimune Group, Inc.'s state of incorporation?
Replimune Group, Inc. is incorporated in Delaware.
What is the principal executive office address for Replimune Group, Inc.?
The address is 500 Unicorn Park Drive Suite 303, Woburn, MA 01801.
What is the filing date for this Form 8-K?
The filing date is November 12, 2024.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-11-12 08:05:23
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share REPL The Nasdaq Stock Mar
Filing Documents
- tm2428095d1_8k.htm (8-K) — 26KB
- tm2428095d1_ex99-1.htm (EX-99.1) — 54KB
- 0001104659-24-116413.txt ( ) — 259KB
- repl-20241112.xsd (EX-101.SCH) — 3KB
- repl-20241112_lab.xml (EX-101.LAB) — 33KB
- repl-20241112_pre.xml (EX-101.PRE) — 22KB
- tm2428095d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On November 12, 2024, Replimune Group, Inc. (the "Company") issued a news release announcing its financial results for the second fiscal quarter ended September 30, 2024 and certain corporate updates. A copy of the news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly stated by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 News Release dated November 12, 2024 104 Cover page interactive data file (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REPLIMUNE GROUP, INC. Date: November 12, 2024 By: /s/ Sushil Patel Sushil Patel Chief Executive Officer